Synthetic and natural mTOR inhibitors for the treatment of cancer and other diseases caused by over-activation of mTOR
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F21%3A00013319" target="_blank" >RIV/00023736:_____/21:00013319 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.52305/YMMO9010" target="_blank" >https://doi.org/10.52305/YMMO9010</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.52305/YMMO9010" target="_blank" >10.52305/YMMO9010</a>
Alternative languages
Result language
angličtina
Original language name
Synthetic and natural mTOR inhibitors for the treatment of cancer and other diseases caused by over-activation of mTOR
Original language description
The human mechanistic target of rapamycin (mTOR) i serine/threonine-protein kinase acting at the catalytic subunit of the types of mTOR protein complexes (mTORC1 and mTORC2). These complexes function in cell metabolism, growth, proliferation, survival and autophagy.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Advances in health and disease: vol 48
ISBN
978-1-68507-375-6
Number of pages of the result
37
Pages from-to
51-88
Number of pages of the book
218
Publisher name
Nova Science
Place of publication
New York
UT code for WoS chapter
—